Company Registration Number 09418105 (England and Wales)
NEXT CLINICAL RESEARCH ORGANISATION LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
NEXT CLINICAL RESEARCH ORGANISATION LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
£
£
£
£
Fixed assets
25,701
25,701
Current assets
468,121
487,345
Prepayments and accrued income
59,888
36,950
Creditors: amounts falling due within one year
(97,839)
(420,578)
Net current assets
430,170
103,717
Total assets less current liabilities
455,871
129,418
Creditors: amounts falling due after more than one year
(399,350)
(67,339)
Net assets
56,521
62,079
Capital and reserves
56,521
62,079
Notes to the financial statements
1
Average employees

The average number of persons (including directors) employed by the company during the year was 2 (2023 - 2).

Next Clinical Research Organisation Limited is a private company limited by shares incorporated in England and Wales. The registered office is 47 The Ridgeway, Friern Barnet, London.

 

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.

 

The principle activity of the Company is that of the provision of clinical trails services.

For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

NEXT CLINICAL RESEARCH ORGANISATION LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2024
31 December 2024
- 2 -

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 17 February 2025 and are signed on its behalf by:
A Moschos
Director
Company Registration Number 09418105
2024-12-312024-01-01falseCCH SoftwareCCH Accounts Production 2023.100No description of principal activityA MoschosT HarveyO Sismani2094181052024-01-012024-12-31094181052024-12-31094181052023-12-3109418105core:CurrentFinancialInstruments2024-12-3109418105core:CurrentFinancialInstruments2023-12-3109418105core:Non-currentFinancialInstruments2024-12-3109418105core:Non-currentFinancialInstruments2023-12-3109418105bus:Director12024-01-012024-12-3109418105bus:PrivateLimitedCompanyLtd2024-01-012024-12-3109418105bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3109418105bus:Micro-entities2024-01-012024-12-3109418105bus:AuditExemptWithAccountantsReport2024-01-012024-12-3109418105bus:Director22024-01-012024-12-3109418105bus:Director32024-01-012024-12-3109418105bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP